Baycrest

BrainMatters •Fall/Winter 2024 • 5 Since its founding more than 106 years ago, Baycrest has successfully pulled together a group of donors, staff, and an extended community of partners and volunteers. Working together, this group has been dedicated to eradicating dementia and other cognitive challenges. The results of their efforts speak for themselves, with significant achievements and advancements in innovative patient care and research. At Baycrest, care, education, research, and innovation come together in a spirit of collaboration and inquiry to create a unique entity that is greater than the sum of its parts. Programs are informed by clinicians, scientists, people living with dementia, and their caregivers. It's a truly remarkable undertaking. The work at Baycrest is bolstered by a large database of research volunteers and assessment/data collection tools that include such as Magnetic resonance imaging (MRI), electroencephalogram (EEG), magnetoencephalography (MEG), and eye-trackers as well as expertise in non-invasive brain stimulation approaches. Many of these tools are inaccessible to most seniors' facilities. Here are just a few standout milestones over the years. • The recently formed Baycrest Academy for Research and Education (BARE) includes the internationally recognized cognitive neuroscience centre, Rotman Research Institute and the Baycrest Centre for Education. Led by President and Chief Scientist Dr. Allison Sekuler, BARE combines the best of research and education and amplifies the best of both functions. • For several years Baycrest has been ranked the #1 most research- intensive hospital in Canada by Research Infosource. Many Baycrest scientists are ranked by Stanford University among the most highly cited in the world. • Baycrest is the scientific headquarters of the Canadian Consortium on Neurodegeneration in Aging (CCNA), which includes more than 300 leading dementia researchers across Canada. Led by Baycrest's Dr. Howard Chertkow, the CCNA is Canada's largest federally funded dementia research program. • The Anne & Allan Bank Centre for Clinical Research Trials at Baycrest conducts more dementia-related studies of new, emerging therapies than any other site in Canada, from pharmaceuticals to novel interventions such as non-invasive brain stimulation. • Baycrest President & CEO Dr. William Reichman co-chaired the Government of Canada's Ministerial Advisory Board on Dementia, tasked with developing the nation's dementia strategy. DOCTORS, SCIENTISTS, PATIENTS AND CAREGIVERS COLLABORATE TO ERADICATE DEMENTIA Dr. Allison Sekuler President & Chief Scientist, Baycrest Academy for Research and Education, Sandra A. Rotman Chair in Cognitive Neuroscience, Rotman Research Institute, Baycrest Academy for Research and Education at Baycrest Centre for Geriatric Care, President & Chief Scientist, Centre for Aging + Brain Health Innovation, powered by Baycrest (CABHI) Dr. William Reichman President & CEO, Baycrest Seniors Care Dr. Howard Chertkow Chair in Cognitive Neurology and Innovation Director, Kimel Family Centre for Brain Health & Wellness, Senior Scientist, Rotman Research Institute, Clinical Advisor, Centre for Aging + Brain Health Innovation, powered by Baycrest (CABHI), Director, Anne & Allan Bank Centre for Clinical Research Trials, Scientific Director, Canadian Consortium on Neurodegeneration in Aging

• Cover